| Article/Paper |
|
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases.
|
 |
Harris RA. et al.; Inflamm Bowel Dis. 2012 Mar 29. doi: 10.1002/ibd.22956
Paper 05/2012 - commentary by Prof Dr G. Kullak
|
|
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
|
|
Sandborn WJ. et al.; Gastroenterology. 2012 Feb;142(2):257-65.e1-3.
Paper 04/2012 - commentary by PD Dr Ch. Mottet
|
|
Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis.
|
|
Ananthakrishnan AN. et al.; Am J Gastroenterol. 2011 Nov;106(11):2009-17. doi: 10.1038/ajg.2011.237.
Paper 03/2012 - commentary by commentary Dr P. Heer
|
|
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
|
|
Louis E. et al.; Gastroenterology. 2012 Jan;142(1):63-70
Paper 02/2012 - commentary by commentary by commentary by Prof Dr P. Michetti
|
|
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
|
|
Van Assche G. et al.; Gut. 2011 Sep 23.
Paper 12/2011 - commentary by Prof Dr Dr G. Rogler
|
|
FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease.
|
|
Evstatiev R. et al.; Gastroenterology. 2011 Sep;141(3):846-853.e2
Paper 10/2011 - commentary by Prof Dr A. Straumann
|
|
Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
|
|
Ali RA. et al.;Clin Gastroenterol Hepatol. 2011 Jul;9(7):584-9.e1-2.
Paper 09/2011 - commentary by PD Dr F. Froehlich
|
|
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
|
|
Taxonera C. et al.;Aliment Pharmacol Ther., 2011 Feb;33(3):340-8.
Paper 08/2011 - commentary by Dr C. Oneta
|
|
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
|
|
Vavricka SR. et al.; Inflamm Bowel Dis. 2011 Apr 20. doi: 10.1002/ibd.21719.
Paper 07/2011 - commentary by Dr A. Schoepfer
|
|
The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomes.
|
|
Sharkey L. et al.; J Crohns Colitis. 2011 Apr;5(2):91-4.
Paper 06/2011 - commentary by Prof Dr F. Seibold
|
|
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.
|
|
De Filippo C. et al.; Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691-6
Paper 05/2011 - commentary by Prof Dr Ch. Müller
|
|
A Prospective Population-Based Study of Triggers of Symptomatic Flares in IBD
|
|
Bernstein CN et al.; Am J Gastroenterol. 2010 Sep;105(9):1994-2002
Paper 03/2011 - commentary by Dr P. Heer
|
|
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977-2008.
|
|
Lakatos PL et al.; J Crohns Colitis. published online 14 September 2010.
Paper 01/2011 - commentary by PD Dr Ch. Mottet
|
